Risk factors for relapse of IgG4-related disease: a systematic review and meta‑analysis
Clinical Rheumatology · 2025-10 · 44 (10) · 4137-4147
DOI: 10.1007/s10067-025-07641-3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Rheumatology, online erschienen am 19.08.2025. Verfasst von Fan Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, No.95 Yong'an Road, Xicheng District, Beijing, China. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: Patients with IgG4-related disease (IgG4-RD) suffer high relapse during long-term treatment, but risk factors associated with relapse are not well established. This study aims to review the potential risk factors and integrate relapse rates of observational studies for IgG4-RD. METHOD: Relevant articles published up to January 28, 2025, were comprehensively and systematically identified from PubMed, EMBASE, and Web of Science databases. A systematic review and meta-analysis was performed to estimate pooled odds ratios (ORs), hazard ratios (HRs), and 95% confidence interval (CI). RESULTS: Twenty-four studies comprising 3797 patients were included. Our findings reveal that a history of allergies (OR: 2.97, 95%CI: 2.07-4.25, P < 0.001), multi-organ involvement (HR: 1.60, 95% CI: 1.23-2.09, P = 0.0005), and decreased complement levels (HR: 2.27, 95% CI: 1.04-4.93, P = 0.04) are significantly associated with relapse. Furthermore, the combination of corticosteroids and immunosuppressants significantly reduces relapse rates (HR: 0.25, 95% CI: 0.10-0.62, P = 0.003). The pooled 12-, 24-, and 36-month relapse rates were 17% (95% CI: 0.10-0.24), 26% (95% CI: 0.22-0.31) and 33% (95% CI: 0.26-0.39), respectively. CONCLUSIONS: This meta-analysis indicated that a history of allergy, multi-organ involvement, and decreased complement levels were risk factors for IgG4-RD relapse. Besides, corticosteroid combined with immunosuppressant therapy could decrease relapse rates. Key Points • A history of allergy, multi-organ involvement, and decreased complement levels were risk factors for IgG4-RD relapse. • The combination of corticosteroids and immunosuppressants could reduces relapse rates of IgG4-RD. • The 12-, 24- and 36-month relapse rates of IgG4-RD were 17%, 26% and 33%, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, No.95 Yong'an Road, Xicheng District, Beijing, China.
- Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, No.95 Yong'an Road, Xicheng District, Beijing, China. Liuyanying6850@126.com.
Zitieren
APA
Yang, F., Wang, T., & Liu, Y. (2025). Risk factors for relapse of IgG4-related disease: a systematic review and meta‑analysis. Clinical Rheumatology, 44(10), 4137-4147. https://doi.org/10.1007/s10067-025-07641-3
Vancouver
Yang F, Wang T, Liu Y. Risk factors for relapse of IgG4-related disease: a systematic review and meta‑analysis. Clinical Rheumatology. 2025;44(10):4137-4147. doi:10.1007/s10067-025-07641-3
BibTeX
@article{Yang2025,
author = {Yang, Fan and Wang, Tianqi and Liu, Yanying},
title = {Risk factors for relapse of IgG4-related disease: a systematic review and meta‑analysis},
journal = {Clinical Rheumatology},
year = {2025},
volume = {44},
number = {10},
pages = {4137--4147},
doi = {10.1007/s10067-025-07641-3}
}
EUVIMED